In vitro comparison of Dhvar-5 and gentamicin in an MRSA osteomyelitis prevention model

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 6, 2004, Pages 1078-1084

  Faber, Christopher ^a,b   Hoogendoorn, Roel J W ^a   Stallmann, Hein P ^a,b   Lyaruu, D M ^b   van Nieuw Amerongen, Arie ^b   Wuisman, Paul I J M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Antimicrobial peptides; Drug delivery; PMMA beads; Rabbits

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; DHVAR 5; ERYTHROMYCIN; GENTAMICIN; OXACILLIN; PENICILLIN G; POLY(METHYL METHACRYLATE); UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT; HISTATIN 5; MICROSPHERE; PEPTIDE; POLYMETHACRYLIC ACID; POLYMETHACRYLIC ACID DERIVATIVE; SALIVA PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; FEMUR; HISTOPATHOLOGY; IN VIVO STUDY; INOCULATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OSTEOMYELITIS; RABBIT; STAPHYLOCOCCUS INFECTION; ANIMAL; ANTIBIOTIC PROPHYLAXIS; CHEMISTRY; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; HUMAN; MICROBIOLOGY; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; DISEASE MODELS, ANIMAL; FEMUR; GENTAMICINS; HUMANS; METHICILLIN RESISTANCE; MICROSPHERES; OSTEOMYELITIS; PEPTIDES; POLYMETHACRYLIC ACIDS; RABBITS; SALIVARY PROTEINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 12344324777     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh441     Document Type: Article

References (37)

1. Walenkamp, G. H., Kleijn, L. L. & de Leeuw, M. (1998). Osteomyelitis treated with gentamicin-PMMA beads: 100 patients followed for 1-12 years. Acta Orthopaedica Scandinavica 69, 518-22.
2. Wahlig, H., Dingeldein, E., Bergmann, R. et al. (1978). The release of gentamicin from polymethylmethacrylate beads. An experimental and pharmacokinetic study. Journal of Bone and Joint Surgery. British volume 60-B, 270-5.
3. Witte, W. (1999). Antibiotic resistance in Gram-positive bacteria: epidemiological aspects. Journal of Antimicrobial Chemotherapy 44, Suppl. A, 1-9.
4. Kac, G., Buu-Hoi, A., Herisson, E. et al. (2000). Methicillin-resistant Staphylococcus aureus. Nosocomial acquisition and carrier state in a wound care center. Archives of Dermatology 136, 735-9.
5. Neut, D., van de Belt, H., Stokroos, I. et al. (2001). Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. Journal of Antimicrobial Chemotherapy 47, 885-91.
6. Whitener, C. J., Park, S. Y., Browne, F. A. et al. (2004). Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clinical Infectious Diseases 38, 1049-55.
7. Hancock, R. E. (1997). Peptide antibiotics. Lancet 349, 418-22.
8. Zasloff, M. (2002). Antimicrobial peptides of multicellular organisms. Nature 415, 389-95.
9. van't Hof, W., Veerman, E. C., Helmerhorst, E. J. et al. (2001). Antimicrobial peptides: properties and applicability. Journal of Biological Chemistry 382, 597-619.
10. Helmerhorst, E. J., Reijnders, I. M., van't Hof, W. et al. (1999). A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides. FEBS Letters 449 105-10.
11. Helmerhorst, E. J., van't Hof, W., Veerman, E. C. et al. (1997). Synthetic histatin analogues with broad-spectrum antimicrobial activity. Biochemical Journal 326, 39-45.
12. Helmerhorst, E. J., Breeuwer, P., van't Hof, W. et al. (1999). The cellular target of histatin 5 on Candida albicans is the energized mitochondrion. Journal of Biological Chemistry 274 7286-91.
13. Ruissen, A. L., Groenink, J., Helmerhorst, E. J. et al. (2001). Effects of histatin 5 and derived peptides on Candida albicans. Biochemical Journal 356, 361-8.
14. Lyaruu, D., van t Hof, W. & Veerman, E. C. (2000). Antimicrobial activity of human saliva histatin analogues against methicillin-resistant S. aureus (MRSA). Journal of Dental Research 79, 227.
15. Faber, C., Stallmann, H. P., Lyaruu, D. M. et al. (2003). Release of antimicrobial peptide Dhvar-5 from polymethylmethacrylate beads. Journal of Antimicrobial Chemotherapy 51, 1359-64.
16. Nijhof, M. W., Dhert, W. J., Fleer, A. et al. (2000). Prophylaxis of implant-related staphylococcal infections using tobramycin-containing bone cement. Journal of Biomedical Materials Research 52, 754-61.
17. Theuns, H. M., Bekker, H., Fokkenrood, H. et al. (1993). Methylmethacrylate embedding of undecalcified rat bone and simultaneous staining for alkaline and tartrate resistant acid phosphatase. Bone 14, 545-50.
18. Klein, C. P., Sauren, Y. M., Modderman, W. E. et al. (1994). A new saw technique improves preparation of bone sections for light and electron microscopy. Journal of Applied Biomaterials 5 369-73.
19. Smeltzer, M. S., Thomas, J. R., Hickmon, S. G. et al. (1997). Characterization of a rabbit model of staphylococcal osteomyelitis. Journal of Orthopaedic Research 15, 414-21.
20. Nijhof, M. W., Stallmann, H. P., Vogely, H. C. et al. (2000). Prevention of infection with tobramycin-containing bone cement or systemic cefazolin in an animal model. Journal of Biomedical Materials Research 52, 709-15.
21. Norden, C. W., Myerowitz, R. L. & Keleti, E. (1980). Experimental osteomyelitis due to Staphylococcus aureus or Pseudomonas aeruginosa: a radiographic-pathological correlative analysis. British Journal of Experimental Pathology 61, 451-60.
22. Harle, A. & Ritzerfeld, W. (1979). The release of gentamicin into the wound secretions from polymethylmethacrylate beads. A study with reference to the animal experiment. Archives of Orthopaedic Trauma Surgery 95, 65-70.
23. Denis, O., Nonhoff, C., Byl, B. et al. (2002). Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. Journal of Antimicrobial Chemotherapy 50, 383-91.
24. Hornberg, C., Schafer, T. R., Koller, A. et al. (2003). The MRSA patient in technical orthopaedics and rehabilitation. Orthopäde 32, 213-7.
25. Hornberg, C., Koller, A., Buhring, W. et al. (2001). Methicillin-resistant Staphylococcus aureus (MRSA). Current status and significance of preventing infection in technical orthopedics. Orthopäde 30, 231-5.
26. Stewart, P. S. & Costerton, J. W. (2001). Antibiotic resistance of bacteria in biofilms. Lancet 358, 135-8.
27. Groenink, J., Walgreen-Weterings, E., van t Hof, W. et al. (1999). Cationic amphipathic peptides, derived from bovine and human lactoferrins, with antimicrobial activity against oral pathogens. FEMS Microbiology Letters 179, 217-22.
28. Levin, M., Quint, P. A., Goldstein, B. et al. (2000). Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group. Lancet 356, 961-7.
29. Nibbering, P. H., Ravensbergen, E., Welling, M. M. et al. (2001). Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. Infection and Immunity 69, 1469-76.
30. Navon-Venezia, S., Feder, R., Gaidukov, L. et al. (2002). Antibacterial properties of dermaseptin S4 derivatives with in vivo activity. Antimicrobial Agents and Chemotherapy 46, 689-94.
31. Steinstraesser, L., Tack, B. F., Waring, A. J. et al. (2002). Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns. Antimicrobial Agents and Chemotherapy 46, 1837-44.
32. Giacometti, A., Cirioni, O., Ghiselli, R. et al. (2002). Potential therapeutic role of cationic peptides in three experimental models of septic shock. Antimicrobial Agents and Chemotherapy 46, 2132-6.
33. Giacometti, A., Cirioni, O., Gov, Y. et al. (2003). RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 47, 1979-83.
34. Giacometti, A., Cirioni, O., Ghiselli, R. et al. (2004). Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock. American Journal of Respiratory and Critical Care Medicine 169, 187-94.
35. Den Hertog, A. L., Wong Fong Sang, H. W., Kraayenhof, R. et al. (2004). Interactions of histatin 5 and histatin 5-derived peptides with liposome membranes: surface effects, translocation and permeabilization. Biochemical Journal 379, 665-72.
36. Wang, Y., Johansson, J., Agerberth, B. et al. (2004). The antimicrobial peptide LL-37 binds to the human plasma protein apolipoprotein A-1. Rapid Communications in Mass Spectrometry 18 588-9.
37. Lorain, V. (1996). Antibiotics in Laboratory Medicine. Williams & Wilkins, Baltimore, MD, USA.